Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with 18F-dopa brain PET in normal controls and patients with Parkinson's disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 8, 2011, Pages 1550-1559

  Oehme, Liane ^a   Perick, Maria ^a   Beuthien Baumann, Bettina ^a,b   Wolz, Martin ^a   Storch, Alexander ^a   Löhle, Matthias ^a   Herting, Birgit ^a   Langner, Jens ^b   Van Den, HoffJörg ^a,b   Reichmann, Heinz ^a   Kotzerke, Jörg ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

18F Dopa; Dopamine turnover; Normal values; Parkinson's disease; PET

Indexed keywords

6 FLUORODOPA F 18; DOPAMINE;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC TEST ACCURACY STUDY; DOPAMINE METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TURNOVER TIME;

CASE-CONTROL STUDIES; DIHYDROXYPHENYLALANINE; DOPAMINE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOSTRIATUM; OCCIPITAL LOBE; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 80052564367     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1819-8     Document Type: Article

References (25)

1. Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998;29:37-61. (Pubitemid 28155704)
2. Buchert R, Thiele F. The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters. Nuklearmedizin 2008;47:167-74.
3. Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 1996;16:42-52.
4. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584-90. (Pubitemid 16218234)
5. Holden JE, Doudet D, Endres CJ, Chan GL, Morrison KS, Vingerhoets FJ, et al. Graphical analysis of 6-fluoro-L-dopa trapping: Effect of inhibition of catechol-O-methyltransferase. J Nucl Med 1997;38:1568-74. (Pubitemid 27443957)
6. Sossi V, Doudet DJ, Holden JE. A reversible tracer analysis approach to the study of effective dopamine turnover. J Cereb Blood Flow Metab 2001;21:469-76. (Pubitemid 32298893)
7. Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during PET with FDOPA. Synapse 2001;41:212-8. (Pubitemid 32691503)
8. Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, et al. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse 1998;29:225-32. (Pubitemid 28267931)
9. Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, et al. Increase in dopamine turnover occurs early in Parkinson's disease: Evidence from a new modeling approach to PET 18F-fluorodopa data. J Cereb Blood Flow Metab 2002;22:232-9. (Pubitemid 34135654)
10. Fahn S, Elton RL, UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson's disease. vol 2. Florham Park: Macmillan Health Care Information; 1987. p. 153- 163, 293-304.
11. Hoffman JM, Melega WP, Hawk TC, Grafton SC, Luxen A, Mahoney DK, et al. The effects of carbidopa administration on 6- [18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med 1992;33:1472-7.
12. Füchtner F, Zessin J, Mäding P, Wüst F. Aspects of 6-[18F]fluoro- L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11. Nuklearmedizin 2008;47:62-4. (Pubitemid 351272813)
13. Füchtner F, Preusche S, Mäding P, Zessin J, Steinbach J. Factors affecting the specific activity of [18F]fluoride from a [18O]water target. Nuklearmedizin 2008;47:116-9. (Pubitemid 351881406)
14. Langner J, Bühler P, Just U, Pötzsch C, Will E, van den Hoff J. Optimized list-mode acquisition and data processing procedures for ACS2 based PET systems. Z Med Phys 2006;16:75-82.
15. Bühler P, Just U, Will E, Kotzerke J, van den Hoff J. An accurate method for correction of head movement in PET. IEEE Trans Med Imaging 2004;23:1176-85.
16. Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD. The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuroimage 2010;50:524-31.
17. Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. Brain 1999;122(Pt 9):1637-50. (Pubitemid 29425668)
18. Goldstein DS, Holmes C, Sewell L, Kopin IJ. Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity. J Nucl Med 2009;50:1479-82.
19. Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls. Eur J Nucl Med Mol Imaging 2009;36:454-62.
20. Jokinen P, Helenius H, Rauhala E, Brück A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med 2009;50:893-9.
21. Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bönner J, et al. Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36:176-82. (Pubitemid 24239234)
22. Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, et al. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: Ratio method versus graphical approach. J Nucl Med 2002;43:1324-30.
23. Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: Correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 2006;26:358-70.
24. Kaasinen V, Nurmi E, Brück A, Eskola O, Bergman J, Solin O, et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: Sex differences in the prefrontal cortex. Brain 2001;124:1125-30. (Pubitemid 32510380)
25. Ghaemi M, Rudolf J, Hilker R, Herholz K, Heiss WD. Increased pineal Fdopa uptake is related to severity of Parkinson's disease-a PET study. J Pineal Res 2001;30:213-9. (Pubitemid 32366570)